COVID-19 associated coagulopathy is correlated with increased age and markers of inflammation response
References
- 1. Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARSCoV-2 and COVID-19. Nat Rev Microbiol. 2021 Mar; 19(3):141-54. DOI: 10.1038/s41579-020-00459-710.1038/s41579-020-00459-7
- 2. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the chinese center for disease control and prevention. JAMA 2020;323:1239-42. DOI: 10.1001/ jama.2020.264810.1001/jama.2020.2648
- 3. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020;395:1033-4. DOI: 10.1016/S0140-6736(20)30628-010.1016/S0140-6736(20)30628-0
- 4. Levi M, van der Poll T. Inflammation and coagulation. Crit Care Med 2010;38:S26-34. DOI: 10.1097/CCM. 0b013e3181c98d2110.1097/CCM.0b013e3181c98d21
- 5. Lazzaroni MG, Piantoni S, Masneri S, Garrafa E, Martini G, Tincani A, et al. Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation system. Blood Rev. 2021 Mar;46:100745. DOI: 10.1016/j.blre.2020.10074510.1016/j.blre.2020.100745
- 6. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62. DOI: 10.1016/S0140-6736(20)30566-310.1016/S0140-6736(20)30566-3
- 7. Teuwen L, Geldhof V, Pasut A, Carmeliet P. COVID-19: the vasculature unleashed. Nature Rev Immunol. 2020;20:389-91. DOI: 10.1038/s41577-020-0343-010.1038/s41577-020-0343-0724024432439870
- 8. Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost. 2020;18:1324-9. DOI: 10.1111/jth.1485910.1111/jth.14859726473032306492
- 9. Lee SG, Fralick M, Sholzberg M. Coagulopathy associated with COVID-19. CMAJ. 2020 May 25;192(21):E583. DOI: 10.1503/cmaj.20068510.1503/cmaj.200685725997032357997
- 10. Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020 Jun 4;135(23):2033-40. DOI: 10.1182/blood.202000600010.1182/blood.2020006000727382732339221
- 11. Levi M, van der Poll T, Schultz M. Systemic versus localized coagulation activation contributing to organ failure in critically ill patients. Semin Immunopathol. 2012 Jan;34(1):167-79. DOI: 10.1007/s00281-011-0283-710.1007/s00281-011-0283-7323366021805225
- 12. Stouthard JM, Levi M, Hack CE, Veenhof CH, Romijn HA, Sauerwein HP, et al. Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Hae-most. 1996 Nov;76(5):738-42. DOI: 10.1055/s-0038-165065310.1055/s-0038-1650653
- 13. Stirling D, Hannant WA, Ludlam CA. Transcriptional activation of the factor VIII gene in liver cell lines by interleukin-6. Thromb Haemost 1998;79:74-8. DOI: 10.1055/s-0037-161422310.1055/s-0037-1614223
- 14. Kerr R, Stirling D, Ludlam CA. Interleukin 6 and haemostasis. Br J Haematol. 2001 Oct;115(1):3-1. DOI: 10.1046/j.1365-2141.2001.03061.x10.1046/j.1365-2141.2001.03061.x11722403
- 15. Leisman DE, Deutschman CS, Legrand M. Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation. Intensive Care Med. 2020 Jun;46(6):1105-8. DOI: 10.1007/s00134-020-06059-610.1007/s00134-020-06059-6718653532347323
- 16. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-9. DOI: 10.1001/jama.2020.158510.1001/jama.2020.1585704288132031570
- 17. Liu J, Liu Y, Xiang P, Pu L, Xiong H, Li C, et al. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. J Transl Med. 2020 May 20;18(1):206. DOI: 10.1186/ s12967-020-02374-010.1186/s12967-020-02374-0723788032434518
- 18. Muniyappa R, Gubbi S. COVID-19 pandemic, corona-viruses, and diabetes mellitus. Am J Physiol Endocrinol Metab. 2020;318:E736-E741. DOI: 10.1152/ajpendo.00124.202010.1152/ajpendo.00124.2020719163332228322
- 19. Pradhan A, Olsson PE. Sex differences in severity and mortality from COVID-19: are males more vulnerable? Biol Sex Differ. 2020 Sep 18;11(1):53. DOI: 10.1186/ s13293-020-00330-710.1186/s13293-020-00330-7749899732948238
- 20. Wong RS, Wu A, To KF, Lee N, Lam CWK, Wong CK, et al. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. BMJ 2003; 326: 1358-62. DOI: 10.1136/ bmj.326.7403.135810.1136/bmj.326.7403.135816212412816821
- 21. Panesar, NS. What caused lymphopenia in SARS and how reliable is the lymphokine status in glucocorticoid-treated patients? Med Hypotheses 2008; 71: 298-301. DOI: 10.1016/j.mehy.2008.03.01910.1016/j.mehy.2008.03.019713135218448259
- 22. Yang M, Li CK, Li K, Hon KL, Ng MH, Chan PK, et al. Hematological findings in SARS patients and possible mechanisms (review). Int J Mol Med 2004;14:311-5. DOI: 10.3892/ijmm.14.2.31110.3892/ijmm.14.2.311
Language: English
Page range: 387 - 394
Submitted on: Aug 3, 2021
Accepted on: Oct 8, 2021
Published on: Oct 22, 2021
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2021 Laurentiu Stratan, Catalin Tiliscan, Victoria Arama, Mihai Lazar, Angelica Visan, Oana Ganea, Maria I. Trifonescu, Sorin S. Arama, Daniela Ion, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.